<p>@ michaelsalzle Patients with diabetes and chronic disease are at high risk for kidney failure, cardiovascular events, and death. The FLOW trial looked at the safety and efficacy of semaglutide in patients with chronic disease and type 2 diabetes.</p>

@ michaelsalzle Patients with diabetes and chronic disease are at high risk for kidney failure, cardiovascular events, and death. The FLOW trial looked at the safety and efficacy of semaglutide in patients with chronic disease and type 2 diabetes.

94. Effects of Semaglutide on CKD in Patients with Type 2 Diabetes

Become a Paid Subscriber: <a href="https://podcasters.spotify.com/pod/show/michael-salzle/subscribe" target="_blank">https://podcasters.spotify.com/pod/show/michael-salzle/subscribe</a>

Healthspan. The podcast that will add years to your life, and life to your years

Health & Fitness

Fitness

Become a Paid Subscriber: https://podcasters.spotify.com/pod/show/michael-salzle/subscribe Healthspan. The podcast that will add years to your life, and life to your years

Become a Paid Subscriber: <a href="https://podcasters.spotify.com/pod/show/michael-salzle/subscribe" rel="noopener noreferrer">https://podcasters.spotify.com/pod/show/michael-salzle/subscribe</a>

Healthspan. The podcast that will add years to your life, and life to your years

Share 94. Effects of Semaglutide on CKD in Patients with Type 2 Diabetes

Sign up to save your podcasts

94. Effects of Semaglutide on CKD in Patients with Type 2 Diabetes

94. Effects of Semaglutide on CKD in Patients with Type 2 Diabetes

More shows like Healthspan

Coaching Real Leaders

Huberman Lab

The Mel Robbins Podcast